Skip to main content
Caplight Logo









Coyote Bioscience Co., Ltd.

Coyote Bioscience Co., Ltd.

Private
BeijingHealthcare & Life Scienceshttps://coyotebio.com/

Last Round

Series D

Dec 23, 2020

Total Funding Raised

$108.6M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Coyote Bioscience Co., Ltd. is a biotechnology company that develops point-of-care testing (POCT) solutions and fully automated, integrated rapid molecular diagnostic systems.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

point-of-care testingPOCTmolecular diagnosticsportable PCRrapid diagnosticsreal-time PCRsample to answerinfectious disease testingdiagnostic cartridgesautomated PCRqPCRlab-on-a-chippublic health screeningveterinary diagnosticsfood safety testingrazor-and-blades model

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Coyote Bioscience Co., Ltd. Comparables

Compare Coyote Bioscience Co., Ltd. with similar companies based on industry and business-model similarity.

Coyote Bioscience Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Credo Diagnostics Biomedical
86%
Hangzhou LifeReal Biotechnology
85%
Igenesis
83%

Coyote Bioscience Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DDec 23, 2020
Series BNov 1, 2016

Coyote Bioscience Co., Ltd. Investors

Notable investors and investment history

Coyote Bioscience Co., Ltd. investors
InvestorRounds
Legend StarSeries B
Hillhouse InvestmentSeries D
Northern Light Venture CapitalSeries B
SAIF PartnersSeries B
Elevation CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 3040% MoM, reaching 9.3K.

  • Jan 20, 2026

    Monthly visitors grew 823% MoM, reaching 1.5K.

Coyote Bioscience Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Coyote Bioscience Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Coyote Bioscience Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range25
Year Founded2009
Last FundingDec 23, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?